Grace Therapeutics, Inc. (GRCE)

CIK 1444192 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Grace Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202640001140361-26-036125
Sep 10, 202640001493152-26-042152
Sep 1, 202640001140361-26-035318
Sep 1, 202640001140361-26-035319
Sep 1, 202640001140361-26-035316
Sep 1, 202640001140361-26-035317
Aug 31, 2026EFFECT9999999995-26-002839
Aug 24, 2026S-30001140361-26-034189
Aug 19, 202640001493152-26-039124
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097338
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097290
Aug 13, 202610-Q0001140361-26-032632
Aug 13, 20268-K0001140361-26-032644
Aug 11, 2026D0001123292-26-001084
Aug 7, 2026SCHEDULE 13G0001493152-26-036565
Aug 6, 20268-K0001140361-26-031671
Jul 28, 20268-K0001140361-26-029837
Jul 28, 2026DEFA14A0001140361-26-029890
Jul 28, 2026DEF 14A0001140361-26-029889
Jun 18, 202610-K0001140361-26-025662
Jun 18, 20268-K0001140361-26-025669
Jun 18, 20268-K0001140361-26-025667
Jun 5, 20268-K0001140361-26-024269
May 15, 2026SCHEDULE 13G/A0001104659-26-062871
Apr 27, 2026SCHEDULE 13G/A0001493152-26-019071